The demonstration of pericryptal fibroblasts in background mucosa and dysplasia complicating ulcerative colitis

T Yao1, I C Talbot

  • 1St Mark's Hospital, Harrow, UK.

Histopathology
|April 1, 1996
PubMed

Insights

Pericryptal fibroblast reduction in ulcerative colitis mucosa may precede dysplasia development. This reduction, especially in villous changes, may indicate a higher risk for carcinoma development.

Area of Science:

  • Gastroenterology
  • Oncology
  • Cell Biology

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory condition associated with an increased risk of colorectal cancer.
  • Understanding the cellular changes that precede dysplasia and cancer in UC is crucial for early detection and intervention.

Purpose of the Study:

  • To investigate the presence and significance of pericryptal fibroblasts in non-dysplastic and dysplastic mucosa of ulcerative colitis patients.
  • To determine the correlation between pericryptal fibroblast reduction and histological features like goblet cell depletion, villous change, and dysplasia grade.

Main Methods:

  • Immunohistochemistry was employed to detect alpha-smooth muscle actin in pericryptal fibroblasts.
  • Analysis of 68 ulcerative colitis tissue sections, including non-dysplastic and dysplastic mucosa.

Main Results:

  • A reduction in pericryptal fibroblasts was observed in 26% of non-dysplastic mucosa and 50% of dysplastic mucosa.
  • Pericryptal fibroblast reduction significantly correlated with goblet cell depletion and villous changes in non-dysplastic mucosa.
  • The reduction was more pronounced in villous dysplasia compared to non-villous dysplasia, but not related to dysplasia grade or proximity to carcinoma.

Conclusions:

  • Reduced pericryptal fibroblasts in background mucosa may be an early event in the development of dysplasia in ulcerative colitis.
  • The association of pericryptal fibroblast reduction with villous changes supports the hypothesis that villous change is a risk marker for colorectal carcinoma in UC.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...